Target intelligence / Profile preview

Sodium- and chloride-dependent GABA transporter 3 (GAT-3)

Target
GAT-3
Molecular classification
Transporter, Neurotransmitter:sodium symporter (SLC6 family)
01

Overview

Sodium‑ and chloride‑dependent GABA transporter 3 is a membrane protein encoded by the SLC6A11 gene. It belongs to the solute carrier family 6 (SLC6), which includes several neurotransmitter transporters responsible for sodium-dependent uptake mechanisms. Primarily expressed in brain astrocytes and some neurons, it mediates high-affinity reuptake of gamma‑aminobutyric acid (GABA)—the main inhibitory neurotransmitter—by coupling its transport with sodium and chloride ions across cell membranes. This process terminates synaptic transmission at inhibitory synapses by clearing released GABA from the extracellular space, thus regulating neuronal excitability. Dysfunction or altered expression has been linked to neurological diseases such as epilepsy, intellectual disability, behavioral problems, and possibly neurodegenerative disorders due to impaired inhibition within neural circuits.

Other names
GAT-3Solute carrier family 6 member 11SLC6A11
02

Mechanism of action

Drugs that inhibit sodium-dependent GABA transporters block reuptake of extracellular GABA, increasing synaptic/intersynaptic concentrations and enhancing inhibitory signaling. This can reduce neuronal excitability—relevant for anticonvulsant or anxiolytic effects.

03

Biological functions

Reuptake of gamma-aminobutyric acid (GABA) from the synaptic cleft into presynaptic neurons and glial cells, terminating GABAergic neurotransmissionRegulation of extracellular GABA levels to maintain inhibitory tone in the central nervous systemCan also transport beta-alanine, taurine, and hypotaurine to a lesser extent
04

Disease associations

Epilepsy (including temporal lobe epilepsy)Behavioral disordersIntellectual disabilityEvidence suggests involvement in seizure susceptibility and altered neurotransmitter balance in conditions such as Dravet syndrome
05

Safety considerations

Excessive inhibition leading to sedation or cognitive impairment if transporter is blocked too strongly.Disruption of normal inhibitory/exciting balance could provoke paradoxical excitation or worsen certain neurological symptoms.Lack of selective pharmacological agents limits clinical translation.
06

Interacting drugs

Specific drugs directly targeting GAT‑3 are not widely used clinically; however, some experimental compounds and research tools modulate its function.

2 more in the full profile.

07

Biomarkers

Altered expression or function may serve as a biomarker for: Epilepsy risk/severityExpression changes have been observed in animal models with cognitive impairment or epilepsy

Beyond the preview

Go deeper on Sodium- and chloride-dependent GABA transporter 3 (GAT-3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium- and chloride-dependent GABA transporter 3 (GAT-3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call